Llwytho...
Trabectedin is a promising antitumor agent potentially inducing melanocytic differentiation for clear cell sarcoma
Clear cell sarcoma is an aggressive soft tissue sarcoma and highly resistant to conventional chemotherapy and radiation therapy. This devastating disease is defined by EWSR1‐ATF1 fusion gene resulting from chromosomal translocation t(12;22)(q13;q12) and characterized by melanocytic differentiation....
Wedi'i Gadw mewn:
Cyhoeddwyd yn: | Cancer Med |
---|---|
Prif Awduron: | , , , , , , , , , , , , , , , |
Fformat: | Artigo |
Iaith: | Inglês |
Cyhoeddwyd: |
John Wiley and Sons Inc.
2017
|
Pynciau: | |
Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5603837/ https://ncbi.nlm.nih.gov/pubmed/28745431 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1130 |
Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|